Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
- PMID: 28045459
- PMCID: PMC5364359
- DOI: 10.1038/ismej.2016.176
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
Abstract
There is an increasing interest in Faecalibacterium prausnitzii, one of the most abundant bacterial species found in the gut, given its potentially important role in promoting gut health. Although some studies have phenotypically characterized strains of this species, it remains a challenge to determine which factors have a key role in maintaining the abundance of this bacterium in the gut. Besides, phylogenetic analysis has shown that at least two different F. prausnitzii phylogroups can be found within this species and their distribution is different between healthy subjects and patients with gut disorders. It also remains unknown whether or not there are other phylogroups within this species, and also if other Faecalibacterium species exist. Finally, many studies have shown that F. prausnitzii abundance is reduced in different intestinal disorders. It has been proposed that F. prausnitzii monitoring may therefore serve as biomarker to assist in gut diseases diagnostics. In this mini-review, we aim to serve as an overview of F. prausnitzii phylogeny, ecophysiology and diversity. In addition, strategies to modulate the abundance of F. prausnitzii in the gut as well as its application as a biomarker for diagnostics and prognostics of gut diseases are discussed. This species may be a useful potential biomarker to assist in ulcerative colitis and Crohn's disease discrimination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Archer S, Meng S, Wu J, Johnson J, Tang R, Hodin R. (1998). Butyrate inhibits colon carcinoma cell growth through two distinct pathways. Surgery 124: 248–253. - PubMed
-
- Balamurugan R, Rajendiran E, George S, Samuel GV, Ramakrishna BS. (2008). Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol 23: 1298–1303. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
